Effect of VAPcare device in prevention of ventilator associated events in patients on ventilator
- Conditions
- Health Condition 1: B97- Viral agents as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/08/035429
- Lead Sponsor
- Dr Vimal Bhardwaj
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.all the patients aged more than or equal to 18 years, both genders in the emergency and medical/ surgical intensive care units who require artificial ventilation for more than 48 hours
2.the patient/ legally authorized representative/ patient relative, provide written informed consent to participate in the study.
3.Patient should be confirmed having COVID 19 infection by RTPCR/Antigen/CT Scan or any other approved method
4.The patient is intubated within 24 Hours of vapcare device initiation
1.A regular ET tube other than ETT above the cuff suction enabled endotracheal tube
2.A previous diagnosis of
a.Pulmonary tuberculosis
b.HIV
c.Ventricular fibrillation
d.Cardiac arrest
e.Bleeding disorders
f.Pregnancy
g.Severe Head/ neck/ facial injuries
3.Tracheostomy at the time of admission
4.Patients enrolled for another clinical study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Incidence of VAE from date of intubation till 2 days post extubation/tracheostomyTimepoint: From intubation till 2 days post extubation
- Secondary Outcome Measures
Name Time Method Antibiotic usageTimepoint: From intubation till 2 days post extubation;Duration of mechanical ventilationTimepoint: From intubation till 2 days post extubation;Mortality <br/ ><br>Timepoint: From intubation till 2 days post extubation;Volume of secretions collectedTimepoint: From intubation till 2 days post extubation